218 related articles for article (PubMed ID: 27097958)
1. Could intensive anti-hypertensive therapy produce the "J-curve effect" in patients with coronary artery disease and hypertension after revascularization?
Lu W
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1350-5. PubMed ID: 27097958
[TBL] [Abstract][Full Text] [Related]
2. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
[TBL] [Abstract][Full Text] [Related]
3. Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST).
Sava RI; Chen YE; Smith SM; Gong Y; Cooper-DeHoff RM; Keeley EC; Pepine CJ; Handberg EM
J Womens Health (Larchmt); 2020 Feb; 29(2):158-166. PubMed ID: 31403360
[No Abstract] [Full Text] [Related]
4. Impact of left ventricular ejection function on blood pressure-lowering therapy in hypertensive patients with coronary artery disease.
Kikuchi N; Jujo K; Yamaguchi J; Ogawa H; Hagiwara N
J Hypertens; 2016 May; 34(5):1011-8. PubMed ID: 26882041
[TBL] [Abstract][Full Text] [Related]
5. Relationships between blood pressure lowering therapy and cardiovascular events in hypertensive patients with coronary artery disease and type 2 diabetes mellitus: The HIJ-CREATE sub-study.
Kamishima K; Ogawa H; Jujo K; Yamaguchi J; Hagiwara N
Diabetes Res Clin Pract; 2019 Mar; 149():69-77. PubMed ID: 30735770
[TBL] [Abstract][Full Text] [Related]
6. Impacts of serum P-selectin on blood pressure control after PCI in patients with coronary heart disease complicated with hypertension.
Yang FF; Peng F; Xing YB; Yuan M; Ma XC; Li G; Guo HY
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(3 Suppl):78-83. PubMed ID: 28745786
[TBL] [Abstract][Full Text] [Related]
7. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
Hansson L
J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
[TBL] [Abstract][Full Text] [Related]
8. Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort.
Wokhlu A; Smith SM; Gong Y; Handberg EM; Elgendy IY; Bavry AA; Cooper-DeHoff RM; Pepine CJ
J Hypertens; 2018 Feb; 36(2):419-427. PubMed ID: 28938338
[TBL] [Abstract][Full Text] [Related]
9. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
[TBL] [Abstract][Full Text] [Related]
10. Impact of age on clinical outcomes of antihypertensive therapy in patients with hypertension and coronary artery disease: A sub-analysis of the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease.
Kikuchi N; Ogawa H; Kawada-Watanabe E; Arashi H; Jujo K; Sekiguchi H; Yamaguchi J; Hagiwara N
J Clin Hypertens (Greenwich); 2020 Jun; 22(6):1070-1079. PubMed ID: 32475050
[TBL] [Abstract][Full Text] [Related]
11. The 24-h blood pressure measurement may predict mortality and cardiovascular events in hypertensive patients with coronary artery disease.
Dzielińska Z; Prejbisz A; Makowiecka-Cieśla M; Januszewicz A; Tyczyński P; Demkow M; Zieliński T; Kadziela J; Florczak E; Ruzyłło W
Blood Press Monit; 2009 Jun; 14(3):99-102. PubMed ID: 19417635
[TBL] [Abstract][Full Text] [Related]
12. Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]).
Denardo SJ; Messerli FH; Gaxiola E; Aranda JM; Cooper-Dehoff RM; Handberg EM; Gong Y; Champion A; Zhou Q; Pepine CJ
Am J Cardiol; 2010 Aug; 106(4):498-503. PubMed ID: 20691307
[TBL] [Abstract][Full Text] [Related]
13. Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease.
Takamiya Y; Miura S; Kawamura A; Tanigawa H; Zhang B; Iwata A; Nishikawa H; Matsuo K; Shirai K; Saku K
Coron Artery Dis; 2009 Jun; 20(4):288-94. PubMed ID: 19440067
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
Mancia G; Kjeldsen SE; Zappe DH; Holzhauer B; Hua TA; Zanchetti A; Julius S; Weber MA
Eur Heart J; 2016 Mar; 37(12):955-64. PubMed ID: 26590384
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Hypertension: Which Goal for Which Patient?
Jarraya F
Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
[TBL] [Abstract][Full Text] [Related]
16. Impact of visit-to-visit variability and systolic blood pressure control on subsequent outcomes in hypertensive patients with coronary artery disease (from the HIJ-CREATE substudy).
Arashi H; Ogawa H; Yamaguchi J; Kawada-Watanabe E; Hagiwara N
Am J Cardiol; 2015 Jul; 116(2):236-42. PubMed ID: 25966826
[TBL] [Abstract][Full Text] [Related]
17. Low blood pressure and cardiovascular events in diabetic patients with coronary artery disease after revascularization: the CREDO-Kyoto registry cohort-1.
Kai H; Katoh A; Harada H; Niiyama H; Furukawa Y; Kimura T;
Hypertens Res; 2020 Jul; 43(7):715-723. PubMed ID: 32015482
[TBL] [Abstract][Full Text] [Related]
18. Predictors of adverse outcome among patients with hypertension and coronary artery disease.
Pepine CJ; Kowey PR; Kupfer S; Kolloch RE; Benetos A; Mancia G; Coca A; Cooper-DeHoff RM; Handberg E; Gaxiola E; Sleight P; Conti CR; Hewkin AC; Tavazzi L;
J Am Coll Cardiol; 2006 Feb; 47(3):547-51. PubMed ID: 16458134
[TBL] [Abstract][Full Text] [Related]
19. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
20. 2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study.
Bangalore S; Gong Y; Cooper-DeHoff RM; Pepine CJ; Messerli FH
J Am Coll Cardiol; 2014 Aug; 64(8):784-93. PubMed ID: 25145522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
